Mark Alan Smith

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Alan Smith:

Company Role Class Num Shares Value Price $ Report Date Ownership
VistaGen Therapeutics, Inc. CHIEF MEDICAL OFFICER Common Stock 19,915 $34,194 $1.72 30 Jun 2022 Direct

Insider Reports Filed by Mark Alan Smith

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VTGN VistaGen Therapeutics, Inc. 30 Jun 2022 1 +$3,740 4 CHIEF MEDICAL OFFICER 15 Jul 2022, 16:30
VTGN VistaGen Therapeutics, Inc. 01 Mar 2022 1 $0 4 CHIEF MEDICAL OFFICER 03 Mar 2022, 15:16
VTGN VistaGen Therapeutics, Inc. 31 Dec 2021 1 +$4,401 4 CHIEF MEDICAL OFFICER 03 Jan 2022, 15:25
VTGN VistaGen Therapeutics, Inc. 30 Jun 2021 1 +$4,399 4 CHIEF MEDICAL OFFICER 02 Jul 2021, 16:11